Table 1.
Primary serous epithelial ovarian cancer patient demographics.
| Healthy controls | BOD patients | EOC patients | |
|---|---|---|---|
| Number of patients | 33 | 20 | 20 |
| Age | |||
| Mean | 52 | 57 | 57 |
| Median | 50 | 52 | 58 |
| Range | 40–81 | 35–97 | 40–78 |
| SD | 10.08 | 14.36 | 10.46 |
| Stage | |||
| I | — | — | 10 |
| II | — | — | 10 |
| Grade | |||
| 1 | — | — | 1 |
| 2 | — | — | 10 |
| 3 | — | — | 9 |
| GLYCOV value∗ | |||
| Mean | 0.21 | 0.42 | 4.31 |
| Median | 0.13 | 0.38 | 2.90 |
| Range | 0.00–0.83 | 0.02–1.27 | 0.56–12.82 |
| SD | 0.21 | 0.29 | 3.84 |
| CA125 (kU/L) | |||
| Mean | 14.45 | 36.90 | 225.86 |
| Median | 12.00 | 30.50 | 65.50 |
| Range | 6–38 | 12–100 | 6–1474 |
| SD | 6.92 | 24.36 | 375.87 |
∗GLYCOV values were calculated using the relative areas obtained from the MALDI-TOF-MS spectra: (sum of relative areas of m/z 3776.8, 3950.9, 4226.1, 4400.2, 4587.4, 4761.5, 4935.7)/7∗4/ (sum of relative areas of m/z 1579.7, 1783.8, 1987.9 and 2192.0).